Reports
Sale
Global Coronary Stents Market Size, Share, Trends, Analysis: By Type: Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold; By End User: Hospitals, Eye Clinics; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Model, Key Demand Indicators, Key Price Indicators; Supplier Landscape; 2024-2032
Global Coronary Stents Market Outlook
The global coronary stents market size was valued at USD 9.8 billion in 2023, driven by the increasing incidence of coronary stents among people across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 16 billion by 2032.
Coronary Stents: Introduction
Coronary stents are the metallic mesh tubes that are used to keep the coronary arteries open followed by an angioplasty, a procedure which is performed to open the narrowed or blocked blood vessels responsible for the blood supply by removing plaque build-up. This plaque usually accumulates fat and cholesterol inside the artery wall. These blocked vessels are usually referred to as coronary arteries.
Global Coronary Stents Market Analysis
The market growth is driven by the increased prevalence of cardiovascular disease (CVD) and the increase in the number of angioplasties. CVD remains the leading cause of mortality for men and women worldwide. Each year around 60 million people across the world develop heart or circulatory disease.
The coronary stents market growth is further driven by factors such as approvals by the U.S. Food and Drug Administration (FDA) for new equipment with substantial potential to treat the condition effectively and reduce the burden globally. For example, the BioFreedom Drug Coated Coronary Stent (DCS) System – P190020 (drug eluting stent) from Biosensors International, received FDA approval this year. The BioFreedom Drug Coated Coronary Stent System is targeted to treat coronary arteries caused by coronary artery disease. Coronary arteries are blood vessels that have been narrowed due to the accumulation of plaque in the inside of the arteries. The approval of such innovative equipment increases the demand for innovations in the market and facilitates the healthcare provider to perform angioplasty procedures with ease, further bolstering the global coronary stents market demand.
The market growth is further attributed to the mergers and acquisitions by market key players exemplified by the acquisition of Taewoong Medical, South Korean stent maker by Olympus, Japanese medical device maker for about USD 370 million as their second biggest acquisition of all times. Such acquisitions mark an achievement in Olympus’s portfolio as they will now be expected to have access to the sources of Taewoong Medical which is expected to boost the market growth further.
Global Coronary Stents Market Segmentations
Market Breakup by Type
- Bare Metal Stents
- Drug Eluting Stents
- Bioresorbable Vascular Scaffold
Market Breakup by End User
- Hospitals
- Eye Clinics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Coronary Stents Market Overview
The market is significantly driven by the increasing prevalence of coronary heart disease globally. The increasing prevalence of coronary heart disease is contributing to the increased incidence of angioplasties in the market as well. Furthermore, the market's key players are focused on developing technologically advanced stents to treat the medical condition with minimally invasive procedures. The increasing preference of people for minimally invasive procedures is a major factor contributing to the global coronary stents market share.
Geographically, North America has been leading the market growth and is expected to lead in the forecast period. The market is further driven by the increased prevalence as according to the Centers for Disease Control and Prevention, Heart Diseases claim a death every 33 seconds in the United States. The market is further driven by the strategic initiatives by the governments in spreading awareness about coronary artery and heart diseases.
Global Coronary Stents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Medtronic Plc
- Boston Scientific Corporation
- Terumo Corporation
- B Braun Melsungen AG
- Biotronik
- Stentys SA
- C. R. Bard, Inc.
- Metabiomics
- MicroPort Scientific Corporation
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Coronary Stents Market Overview
3.1 Global Coronary Stents Market Historical Value (2017-2023)
3.2 Global Coronary Stents Market Forecast Value (2024-2032)
4 Global Coronary Stents Market Landscape
4.1 Global Coronary Stents: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Coronary Stents: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Coronary Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Coronary Stents Market Segmentation
6.1 Global Coronary Stents Market by Type
6.1.1 Market Overview
6.1.2 Bare Metal Stents
6.1.3 Drug Eluting Stents
6.1.4 Bioresorbable Vascular Scaffold
6.2 Global Coronary Stents Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Eye Clinics
6.3 Global Coronary Stents Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Coronary Stents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Coronary Stents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Coronary Stents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Coronary Stents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Coronary Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Abbott
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Medtronic Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Boston Scientific Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Terumo Corporation
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 B Braun Melsungen AG
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Biotronik
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Stentys SA
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 C. R. Bard, Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Metabiomics
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 MicroPort Scientific Corporation
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 9.8 billion in 2023, driven by the increased incidence of angioplasty.
The market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 and is likely to reach a market value of USD 16 billion by 2032.
The increasing prevalence of coronary heart disease, along with increasing research and development activities, are the key factors bolstering the market growth.
The rising number of FDA approvals for the development of innovative and more effective stents is a major trend influencing market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The types can be categorised into bare metal stents, drug eluting stents, and bioresorbable vascular scaffolds.
End users in the market are hospitals and eye clinics.
Key players involved in the market are Abbott, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, C. R. Bard, Inc., Metabiomics, and MicroPort Scientific Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER